IVVD

0.41277.45%
TG

Terrance G. McGuire

Independent Director

Mr. Terrance G. McGuire, also known as Terry, M.B.A., M.S., is Founding Partner of Polaris Venture Partners, Inc., which he joined in 1996. At the firm, he also served as General Partner. He serves as Director of Soufflé Therapeutics, Inc. He is Founding Partner of Polaris Growth Management, L.L.C., Founding Partner of LS Polaris Innovation Fund Management, L.L.C. and Co-Owner of Polaris Founders Capital Management Co I, LLC. He is Co-Founder of Microchips Biotech, Inc., which he joined in 1999 and also serves as Director. He serves as Independent Director at Seer, Inc. since December 2017 and as Independent Director at Invivyd, Inc. since October 2020. He serves as Director of WHI Solutions, Inc., SustainX Inc., Adimab, LLC, Iora Health, Inc., AeroDesigns, Inc., Quantum Designs, LLC, Faraday Pharmaceuticals, Inc., Jnana Therapeutics Inc., Arthur Rock Center for Entrepreneurship and Ankyra Therapeutics, Inc. He is a Member of the Board of Directors and Member of the Advisory Board of Ingenium Pharmaceuticals GmbH, a Member of the Advisory Board and Director of Life Line Screening of America, Ltd. and a Member of the Advisory Board of Mountain Group Capital, LLC. He serves as Board Observer of Arsenal Medical, Inc. since 2022. He also serves on the boards of The Healthcare Initiative Advisory Board at Harvard Business School and The Brigham Research Institute’s Scientific Advisory Board. aHe served as Independent Director at Tectonic Therapeutic, Inc. from April 1, 2026 to June 8, 2026 and as Independent Chairman of the Board until April 1, 2026. He served as Independent Director at Cyclerion Therapeutics, Inc. from April 1, 2019 to August 2024. He served as Independent Director at Alector, Inc. from 2013 to March 20, 2024. He served as Director at Arsenal Medical, Inc. until 2022. He served as Chairman of Ironwood Pharmaceuticals, Inc. from 2015 to April 1, 2019 and was employed at the company from 1998 to April 1, 2019. He served as Director at Pulmatrix, Inc. from May 2006 to September 2019. He served as Director at Acceleron Pharma Inc. from 2005 to November 15, 2017. He was a Member of the Advisory Board at Adnexus Therapeutics, Inc., where he was employed until 2017. He served as Chairman of the National Venture Capital Association, where he was employed until December 2015. He served as Director at Trevena, Inc. from January 2008 to December 2015. He served as Director at Cerulean Pharma Inc., where he was employed until December 2015. He served as Lead Independent Director at DGI Resolution, Inc. from August 1996 to December 1, 2008. He served as Director at Arsanis, Inc. from February 2011. He served as Director at Biolex Therapeutics, Inc., which he joined in September 2005. He served as Director at Acusphere, Inc., which he joined in 1994. He is Co-Founder of Advanced Inhalation Research, Inc. and Co-Founder of Inspire Pharmaceuticals, Inc., where he also served as Director. He also served as General Partner at Beta Partners; General Partner at Burr, Egan, Deleage & Co.; Investment Professional of GTCR LLC; Partner at Golder, Thoma and Cressey; Vice Chairman of the Board of TransForm Pharmaceuticals, Inc.; and Director of Akamai Technologies, Inc., Alimera Sciences, Inc., Aspect Medical Systems, Inc., Biomarin Pediatrics II, Inc., CodeRyte, Inc., Cogenics Icoria, Inc., Cubist Pharmaceuticals LLC, DeCode, Editas Medicine, Inc., GlycoFi, Inc., Integ Incorporated, Kallyope, Lyra Therapeutics, Inc., The Massachusetts Medical Device Industry Council and X4 Pharmaceuticals, Inc. He was also a Director and Member of the Advisory Board of Pervasis Therapeutics, Inc., a Member of the Board of Incredible Foods, Inc., a Member of the Advisory Board and Director of Remon Medical Technologies Ltd. and a Member of the Advisory Board of NDO Surgical, Inc. He focuses on Life Sciences, Healthcare, Medical and Information Technology and Early Stage investing. He co-founded Inspire Pharmaceuticals, Advanced Inhalation Research, Inc. (AIR) and Microchips Biotech, Inc. (MicroCHIPS). He helped create and has chaired the Global Venture Capital Congress (GVCC). During his tenure as Chairman of the National Venture Capital Association (NVCA), he testified before Congress for the Dodd-Frank Wall Street Reform and Consumer Protection Act. His awards include being listed in Scientific American’s Worldview 100, the Irish America Healthcare & Life Sciences 50 Award, Forbes’ Top Life Sciences Investors, The Boston Irish Business Award and Forbes’ Midas 100 List of Top Tech Investors. He is also a recipient of the Massachusetts Society for Medical Research Award, the Albert Einstein Award for Outstanding Achievement in the Life Sciences and The Outstanding Service Award from the NVCA. He has an M.B.A. from Harvard Business School, an M.S. in Engineering from Thayer School Of Engineering, Dartmouth College and a B.S. in Physics & Economics from Hobart & William Smith Colleges. He was also awarded an Hon Doc in Law from Canisius College and an Hon Doc in Law from Ohio Wesleyan University.

Positions